Doctors Note Logo

Published on: 10/27/2026

Child Swallowed Adult 2mg Imodium: Central Nervous System and Cardiac Risks

A single adult 2mg Imodium (loperamide) tablet can be dangerous for a young child, because children under 6 are far more sensitive to its effects on the brain and heart. Reported reactions include drowsiness, slowed or shallow breathing, severe constipation with abdominal swelling (paralytic ileus or toxic megacolon), and, at higher exposures, QT prolongation and life-threatening arrhythmias such as torsades de pointes. Symptoms may be delayed for hours, so a child who seems fine at first can still be at risk, and dose per body weight, timing, and any vomiting all change the picture. Several important factors determine urgency, including age, weight, number of tablets, and warning signs that require emergency care, so see below for the complete details before deciding what to do next.

If your child has swallowed loperamide and you are unsure how serious it is, a free, instant, online symptom check can help you sort out which symptoms point to an emergency and which next steps make sense, giving you clear guidance in minutes while you contact Poison Control or your pediatrician.

Last reviewed for medical accuracy: 10/27/2026

answer background

Concerned about your symptoms?

Explanation

Child Swallowed Adult 2 mg Imodium: Central Nervous System and Cardiac Risks

If your child swallowed an adult Imodium capsule, contact a poison control center or a medical professional now—even if the child seems well. Imodium contains loperamide, a medicine that slows diarrhea by acting on opioid receptors in the intestine. At recommended doses, very little loperamide reaches the brain. In an overdose, however, it can affect the central nervous system (CNS) and the heart.

A single 2 mg capsule is not automatically a life-threatening dose, particularly in an older or larger child, but the risk cannot be judged safely from the capsule strength alone. The child’s age, weight, medical history, other medicines, the amount swallowed, and whether the product was an extended-release or combination product all matter.

What to do immediately

  • Call Poison Control or your local poison center now. In the United States, call 1-800-222-1222. In other countries, contact the local poison information service or emergency department.
  • If the child is unconscious, difficult to wake, having trouble breathing, having a seizure, fainting, or has an abnormal heartbeat, call your local emergency number immediately.
  • Remove any remaining capsules from the child’s reach.
  • Keep the package nearby. Poison specialists will want to know the exact product, strength, number of capsules possibly swallowed, and time of ingestion.
  • Do not make the child vomit.
  • Do not give activated charcoal unless a poison specialist or doctor specifically tells you to.
  • Do not give additional Imodium, opioid medicines, sleep medicines, alcohol, or other drugs that can cause drowsiness.

If possible, note when the capsule was swallowed and whether the child chewed it or swallowed it whole. Do not delay medical advice while trying to calculate the dose yourself.

Central nervous system risks

Loperamide is chemically related to opioid medicines, although ordinary doses are designed to work mainly in the gut. Large amounts can overcome the body’s protective barriers and produce opioid-like effects in the brain.

Possible CNS effects include:

  • Unusual sleepiness or difficulty waking
  • Confusion, agitation, or reduced responsiveness
  • Poor coordination or weakness
  • Pinpoint pupils
  • Slow, shallow, or irregular breathing
  • Loss of consciousness
  • Seizures, particularly in severe poisoning

The most dangerous CNS effect is breathing suppression. A child who is very sleepy may not be breathing adequately, even if the child appears to be sleeping. Watch for slow breathing, pauses, noisy breathing, bluish or gray lips, or difficulty waking the child.

Do not assume that a child who initially looks normal is completely out of danger. Some effects may take time to appear, and the timing can vary depending on the amount taken and the product.

Cardiac risks

Large loperamide overdoses have been linked with serious electrical disturbances in the heart. These may include:

  • A prolonged QT interval on an electrocardiogram
  • Torsades de pointes, a dangerous abnormal rhythm
  • Fast ventricular rhythms
  • Fainting or collapse
  • Cardiac arrest

Some children may have no warning symptoms before a rhythm problem occurs. Others may complain of a racing, pounding, or irregular heartbeat, chest discomfort, dizziness, or lightheadedness. Fainting after a possible loperamide ingestion is an emergency.

The risk is higher with larger amounts, repeated doses, misuse, certain heart conditions, low potassium or magnesium levels, liver disease, and medicines that also affect the heart’s rhythm. Some medicines can also increase loperamide concentrations in the body. For this reason, tell the poison specialist or doctor about all prescription medicines, over-the-counter products, and supplements the child may have taken.

Is one adult 2 mg capsule dangerous?

A standard adult Imodium capsule usually contains 2 mg of loperamide. A single capsule is often less concerning than a large or repeated ingestion, but it should not be automatically dismissed—especially in an infant, toddler, small child, or child with a serious medical condition.

Children are not simply small adults. Their weight, developing nervous system, ability to describe symptoms, and sensitivity to medicines can change the risk. Imodium products are not appropriate for every child, and young children should not receive loperamide unless a qualified clinician specifically recommends it.

Poison Control can use the child’s weight and age to determine whether home observation is reasonable or whether an emergency evaluation is needed. If the amount is unknown, assume that more may have been swallowed until a professional advises otherwise.

When emergency care is needed

Call emergency services or go to an emergency department immediately if the child has any of the following:

  • Trouble breathing, slow breathing, or pauses in breathing
  • Extreme sleepiness, inability to wake, or loss of consciousness
  • Blue, gray, or very pale lips or skin
  • A seizure
  • Fainting, collapse, severe weakness, or marked dizziness
  • A very fast, slow, or irregular heartbeat
  • Chest pain or repeated vomiting with drowsiness
  • Severe confusion, agitation, or unusual behavior

While waiting for help, place an unconscious but breathing child on their side and monitor breathing. Do not leave the child alone. If the child is not breathing normally and you know how to provide CPR, begin emergency first aid while following the dispatcher’s instructions.

What doctors may do

A healthcare professional may monitor the child’s breathing, alertness, blood pressure, and heart rhythm. An ECG may be needed to check for QT prolongation or other rhythm changes. Depending on the timing and amount, the medical team may perform blood tests, observe the child for several hours, or recommend longer monitoring.

Treatment depends on the symptoms and test results. It may include breathing support, medicines for dangerous heart rhythms, correction of electrolyte abnormalities, or an opioid-reversal medicine such as naloxone if significant opioid-like breathing depression occurs. Do not give naloxone at home unless emergency professionals instruct you to do so.

Even if the child has no symptoms, follow the poison center’s observation instructions closely. Do not rely on an online dosage chart or wait for diarrhea, sleepiness, or heart symptoms to develop before seeking advice.

You may also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker, but it should not replace Poison Control, emergency services, or a clinician’s assessment after a possible overdose.

Preventing another accidental ingestion

Store Imodium and all medicines in a locked or secured location, preferably out of sight and reach. Child-resistant packaging reduces risk but does not make it childproof. Keep medicines in their original containers, avoid describing them as “candy,” and count capsules if you suspect a child has accessed them.

A child who swallowed an adult Imodium capsule should be discussed with Poison Control or a doctor promptly. Speak to a doctor about anything that could be life-threatening or serious, including any change in breathing, consciousness, behavior, or heartbeat.

(References)

  • * Ahmad SR. Lomotil overdose. Pediatrics. 1992 May;89(5 Pt 1):980-1. PMID: 1579421.

  • * Schultz M, Schölmerich J, Kullmann F. [Management of chemotherapy induced diarrhea]. Z Gastroenterol. 2004 Jun;42(6):527-38. doi: 10.1055/s-2004-812982. PMID: 15190449.

  • * Leung K. [N-methyl-(11)C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-methyl-butanamide. 2004. PMID: 20641310.

  • * Schneeweiss A, Park-Simon TW, Albanell J, Lassen U, Cortés J, Dieras V, May M, Schindler C, Marmé F, Cejalvo JM, Martinez-Garcia M, Gonzalez I, Lopez-Martin J, Welt A, Levy C, Joly F, Michielin F, Jacob W, Adessi C, Moisan A, Meneses-Lorente G, Racek T, James I, Ceppi M, Hasmann M, Weisser M, Cervantes A. Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. Invest New Drugs. 2018 Oct;36(5):848-859. doi: 10.1007/s10637-018-0562-4. Epub 2018 Jan 19. PMID: 29349598; PMCID: PMC6153514.

  • * Xu C, Ravva P, Dang JS, Laurent J, Adessi C, McIntyre C, Meneses-Lorente G, Mercier F. A continuous-time multistate Markov model to describe the occurrence and severity of diarrhea events in metastatic breast cancer patients treated with lumretuzumab in combination with pertuzumab and paclitaxel. Cancer Chemother Pharmacol. 2018 Sep;82(3):395-406. doi: 10.1007/s00280-018-3621-9. Epub 2018 Jun 18. PMID: 29915982.

  • * Krantz MJ, Palmer RB, Haigney MCP. Cardiovascular Complications of Opioid Use: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Jan 19;77(2):205-223. doi: 10.1016/j.jacc.2020.11.002. PMID: 33446314.

  • * Okajima M, Miura S, Watanabe S, Tanaka H, Ito K, Ishida T, Makino M, Iwashima A, Matsumoto N, Sato K, Ichikawa K, Abe T, Yoshizawa H, Kikuchi T. A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401). Transl Lung Cancer Res. 2021 Jan;10(1):252-260. doi: 10.21037/tlcr-20-649. PMID: 33569309; PMCID: PMC7867768.

  • * Levine M, Lovecchio F. New Designer Drugs. Emerg Med Clin North Am. 2021 Aug;39(3):677-687. doi: 10.1016/j.emc.2021.04.013. Epub 2021 Jun 9. PMID: 34215409.

  • * Font J, Alexandre J, Dolladille C, Milliez P, Ollitrault P. Loperamide-Associated Ventricular Arrhythmias. J Am Coll Cardiol. 2023 Oct 24;82(17):e157-e158. doi: 10.1016/j.jacc.2023.06.054. PMID: 37852700.

  • * Krantz MJ, Stockbridge N, Kao DP, Klein MG, Haigney MCP. Reply: Loperamide-Associated Ventricular Arrhythmias. J Am Coll Cardiol. 2023 Oct 24;82(17):e159. doi: 10.1016/j.jacc.2023.07.033. PMID: 37852701.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.